The study of structure and functioning of proteins is termed as proteomics. Post the arrival of transcriptomics and genomics, proteomics was the next approach in the biological systems. It is considered to be the most intricate study as compared to genomics, because a given organism’s genome remains constant, but the proteome alters with time and cells. Cancer biomarkers assist in diagnosing and determining whether the patients are at a risk of developing cancer by assessing their degree in body fluids or blood. These are metabolites or endogenous proteins which are released by the tumor itself or the body’s response to the presence of cancer cells. Cancer biomarkers also aid in indicating the level of cancer deterioration in the body and the body’s reaction towards the cancer therapies. In 2014, The American Cancer Society (ACS) stated that more than 14 million people were suffering from cancer in the U.S. Moreover in 2015, approximately 1,658,370 new cancer cases were reported. World Health Organization (WHO) predicted that nearly 8.2 million patients died of cancer in 2012 and during the next two decades, almost 70% rise in cases is expected. All of these figures state that cancer is no doubt one of the most deadly diseases associated with greater mortality rates in the world. In addition, it has been found out that more than half of the cancer deaths are due to being diagnosed at an advanced stage. Therefore, early detection assists in taking appropriate preventive measures, slow-down the deterioration process, and better the chances of survival. Due to such reasons there is an imminent demand for sensitive proteomic cancer biomarkers which would be of great help in early diagnosing.
Top Manufactures Analysis of Glass lenses: Abbott Diagnostics, Agilent Technologies, Eli Lilly & Co., EUSA Pharma, CytoCore, Inc.
To Browse Complete Report, Click Here: http://www.qyresearchgroups.com/report/global-proteomic-cancer-biomarkers-sales-market-report-2016
The global proteomic cancer biomarkers sales market is anticipated to register at substantially higher CAGR during the forecast period owing to the far-flung occurrence of cancer cases across the globe. Cancer biomarkers are injected in the body in order to detect, prognosis and epidemiology. They are used to keep a tab of the body’s response to a condition or treatment. Customized treatment routine, capability to diagnose and screen tumor cells, reduced level of time spent on clinical trials, non-invasive diagnosis, cost-efficient, are a few factors which are driving the proteomic cancer biomarkers sales market on a global level. Enhanced technologies, latest medical discoveries, R&D factors, government and private organizations’ expenditure, and increasing collaborations in the biomarker research segment have further impelled this industry’s market. However, greater capital investment and wretched reimbursement along with stringent regulatory systems are predicted to hinder this market’s growth.
To Request Sample Copy of This Report: http://www.qyresearchgroups.com/request-sample/154037
Geographically, North America is dominating the global proteomic cancer biomarkers sales market owing to the flourishing IT sector, robust support from the government and other governmental agencies such as the Food and Drug Administration (FDA), along with elevated need for personalized medicine. Some of the major market players of this industry are CytoCore, Inc.,GE Healthcare, Agilent Technologies, Asuragen, Inc., Abbott Diagnostics, Biomarker Technologies, LLC, Bruker Daltonics, Inc., Eli Lilly & Co., DiagnoCure, Inc., Beckman Coulter, Inc., EUSA Pharma, and BioCurex, Inc..
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world’s most complete and current database of expert insights on global industries, companies, products, and trends.
Room B1510, ShijiKemao Building, No.66, Zhongguancun East Road,
Haidian District, Beijing, 100190, China